Coronary Artery Disease
Coronary artery disease (CAD) remains the leading cause of premature death, and its earliest stages often go unrecognised. The majority of people with CAD have no symptoms, and tragically, sudden death can be the first presentation. Symptoms are therefore unreliable indicators, making early screening absolutely critical. CT scanning of the coronary arteries is currently the most effective method to detect disease at an early stage.
What is less widely appreciated is how early CAD can begin: studies show that 25–35% of people in their 20s and 30s already have early arterial disease. Identifying it at this stage offers the opportunity not just to manage but to reverse the process and address the true drivers before complications occur.
My routine assessment goes far beyond NHS standards and is unrivalled in the UK. In addition to advanced imaging, I use a comprehensive cardiometabolic profile, detailed microbiome analysis to uncover dysbiosis as a driver of vascular inflammation, and testing for oxidative stress, methylation status, and other advanced biomarkers that influence cardiovascular risk. This allows me to build a detailed picture of each patient’s unique risk profile and tailor interventions accordingly.
My goal is not only to reduce risk but to optimise long-term heart health by restoring balance at the deepest biological level. With this integrative approach—combining cutting-edge cardiology, advanced diagnostics, and functional medicine strategies—we can achieve far better outcomes, prevent premature disease, and improve both health and lifespan.

